Skip to content

Study on the central mechanism of multimodal MRI in patients with moderate and severe OSAHS based on neurovascular units

Study on the central mechanism of multimodal MRI in patients with moderate and severe OSAHS based on neurovascular units

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058585
Enrollment
Unknown
Registered
2022-04-12
Start date
2022-04-12
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea hypopnea syndrome (OSAHS)

Interventions

Case group:None
Healthy control group:None

Sponsors

The Third Affiliated Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for OSAHS patients: (1) All patients met the diagnostic criteria of moderate and severe OSAHS and underwent overnight polysomnography (PSG) monitoring (>7h) after respiratory disorder index (AHI) [AHI=(number of apnea + number of hypopnea)/ sleep time (h)x100%]>15 times/h; The condition is relatively stable; (2) Aged 22 to 60 years, no gende limit; (3) No treatment such as positive pressure ventilation and surgery; (4) Right-handedness (handedness was judged according to the criteria of Neurology Department of the First Hospital of Beijing Medical University); (5) Signed informed consent and accepted the experiment voluntarily. 2. Inclusion criteria of healthy volunteers: (1) No OSA or other sleep disorders were confirmed by polysomnographic monitoring; (2) No gender limit, aged 22-60 years; (3) Right-handed; (4) Signed informed consent and accepted the experiment voluntarily.

Exclusion criteria

Exclusion criteria: 1. Abuse illegal drugs or alcohol; 2. Brain MRI found lesions (such as cerebral infarction, cyst, tumor, etc.); 3. There are MRI contraindications (such as claustrophobia, plate implantation, etc.); 4. A history of neurological or psychiatric disorders (e.g. neurodegenerative diseases, epilepsy, brain trauma, depression, peripheral diseases, etc.); 5. Other sleep disorders (such as restless leg syndrome, hypersomnia, primary insomnia and narcolepsy, etc.); 6. History of cardiovascular disease, hypertension and diabetes; 7. Patients with cerebral vascular pathological variation.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;Epworth Sleepiness Score;Low-frequency amplitude ratio;Local consistency;Functional connection;Magnetic resonance spectrum;Arterial spin labeling;

Countries

China

Contacts

Public ContactChen Junqi

The Third Affiliated Hospital of Southern Medical University

meixibao@126.com+86 13450218680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026